FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Vecuronium Bromide for Injection
Status: Currently in Shortage
»Date first posted: 05/06/2020
»Therapeutic Categories: Anesthesia

Expand all

AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.) (Reverified 10/13/2020)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/vial, packages of 10 (NDC 55150-235-10) Backordered. Next release Oct 2020 Production increase in response to increased demand. Demand increase for the drug
20 mg/vial, packages of 10 (NDC 55150-236-20) Backordered — next availability targetted for Nov. 2020 Intermittent availability expected Demand increase for the drug

Gland Pharma (New 05/06/2020)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/vial (NDC 63323-781-10) Currently on backorder; estimate shortage thru Q4 2020. Distributed by marketing partner: Fresenius Kabi LLC (888-386-1300) Demand increase for the drug
20 mg/vial (NDC 63323-782-20) Currently on backorder; estimate shortage thru Q4 2020. Distributed by marketing partner: Fresenius Kabi LLC (888-386-1300) Demand increase for the drug

Hospira, Inc. (Revised 10/22/2020)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg Single Dose Glass Fliptop Vial (NDC 00409-1632-01) Available Other
20 mg Single Dose Glass Fliptop Vial (NDC 00409-1634-01) Limited Supply Available. Next Delivery and Estimated Recovery: December 2020 Demand increase for the drug

Mylan Institutional (Revised 10/14/2020)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Vecuronium Bromide Injection (Lyophilizate in Single Dose Vials) [10 mg](NDC 67457-438-10) Available Demand increase for the drug
Vecuronium Bromide Injection (Lyophilizate in Single Dose Vials) [20 mg](NDC 67457-475-20) Available Demand increase for the drug

Sun Pharmaceutical Industries Inc. (Revised 09/17/2020)

Company Contact Information:
800-818-4555

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg (NDC 47335-931-44) Available Demand increase of the drug
20 mg (NDC 47335-932-44) Available Demand increase of the drug

Teva Pharmaceuticals (Reverified 10/01/2020)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg* 10 X 10 mL *1 mg/mL when reconstituted to 10 mL (NDC 0703-2914-03) Available. We are satisfying historical committed customer demand.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English